Publications
2024
- Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children.Goodwin J, Kajubi R, Wang K, Li F, Wade M, Orukan F, Huang L, Whalen M, Aweeka FT, Mwebaza N, Parikh S. Nat Commun. 2024 May 7; 2024 May 7. PMID: 38714692.
- Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.Lapidus S, Goheen MM, Sy M, Deme AB, Ndiaye IM, Diedhiou Y, Mbaye AM, Hagadorn KA, Sene SD, Pouye MN, Thiam LG, Ba A, Guerra N, Mbengue A, Raduwan H, Vigan-Womas I, Parikh S, Ko AI, Ndiaye D, Fikrig E, Chuang YM, Bei AK. medRxiv. 2024 Apr 22; 2024 Apr 22. PMID: 38712295.
2023
- Lessons Learned from the Connecticut Response to COVID-19 in Nursing Homes during the First 2 Years of the Pandemic.Goodwin J, Harizaj A, Armstrong J, Maloney M, Ehrlich H, Leung V, Parikh S. J Am Med Dir Assoc. 2023 Oct; 2023 Aug 14. PMID: 37591486.
- Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional study.Ehrlich HY, Somé AF, Bazié T, Ebou CN, Dembélé EL, Balma R, Goodwin J, Wade M, Bei AK, Ouédraogo JB, Foy BD, Dabiré RK, Parikh S. Lancet Microbe. 2023 Jun; 2023 Apr 20. PMID: 37086737.
- Moving towards malaria elimination with safer treatment for children with G6PD deficiency.Boum Y, Moukoko CEE, Parikh S. Lancet Infect Dis. 2023 Apr; 2022 Nov 30. PMID: 36462525.
- Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria.Foy BD, Some A, Magalhaes T, Gray L, Rao S, Sougue E, Jackson CL, Kittelson J, Slater HC, Bousema T, Da O, Coulidiaty AGV, Colt M, Wade M, Richards K, Some AF, Dabire RK, Parikh S. JMIR Res Protoc. 2023 Mar 20; 2023 Mar 20. PMID: 36939832.
- Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.Kay K, Goodwin J, Ehrlich H, Ou J, Freeman T, Wang K, Li F, Wade M, French J, Huang L, Aweeka F, Mwebaza N, Kajubi R, Riggs M, Ruiz-Garcia A, Parikh S. Clin Pharmacol Ther. 2023 Mar; 2022 Nov 14. PMID: 36260349.
- The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.Whalen ME, Kajubi R, Goodwin J, Orukan F, Colt M, Huang L, Richards K, Wang K, Li F, Mwebaza N, Aweeka FT, Parikh S. Clin Infect Dis. 2023 Feb 8. PMID: 36130191.
- Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.Nyangulu W, Mungwira RG, Divala TH, Nampota-Nkomba N, Nyirenda OM, Buchwald AG, Miller J, Earland DE, Adams M, Plowe CV, Taylor TE, Mallewa JE, van Oosterhout JJ, Parikh S, Laurens MB, Laufer MK. Malar J. 2023 Jan 27; 2023 Jan 27. PMID: 36707795.
- Striving towards true equity in global health: A checklist for bilateral research partnerships.Hodson DZ, Etoundi YM, Parikh S, Boum Y 2nd. PLOS Glob Public Health. 2023; 2023 Jan 18. PMID: 36963065.